Company profile for Corsera Health

NEW Drugs in Dev.: 1
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Corsera Health is redefining the future of cardiovascular care through early prediction and prevention of atherosclerotic cardiovascular disease (ASCVD). The company is developing a once-annual RNAi therapy designed to prevent cumulative cardiovascular damage. By uniting decades of RNAi innovation with global expertise in disease prediction, manufacturing, evidence generation, and commercialization, Corsera Health aims to tran...
Corsera Health is redefining the future of cardiovascular care through early prediction and prevention of atherosclerotic cardiovascular disease (ASCVD). The company is developing a once-annual RNAi therapy designed to prevent cumulative cardiovascular damage. By uniting decades of RNAi innovation with global expertise in disease prediction, manufacturing, evidence generation, and commercialization, Corsera Health aims to transform the management of heart disease—extending healthspan, reducing healthcare costs, and enhancing overall human productivity.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
101 Federal Street · Suite 1320 · Boston, MA 02110
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251024605879/en/Corsera-Health-Files-First-Phase-1-Clinical-Trial-Application-for-its-Lead-Preventive-RNAi-Medicine-Program-for-Cardiovascular-Disease

BUSINESS WIRE
27 Oct 2025

https://www.fiercebiotech.com/biotech/aiming-disrupt-cardiovascular-space-2-industry-vets-unveil-boston-biotech-preventative-rnai

FIERCE BIOTECH
02 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty